Catecholaminergic polymorphic ventricular tachycardia: important messages from case reports

This editorial refers to 'Germline and somatic mosaicism for a mutation of the ryanodine receptor type 2 gene: implication for genetic counselling and patient caring' by N. Roux-Buisson et al., on page 130 and 'Efficacy of flecainide in a patient with catecholaminergic polymorphic ventricular tachycardia' by E.K. Biernacka and P. Hoffman, on page 129